# Racial disparity in utilization of therapeutic modalities among multiple myeloma patients: a <scp>SEER</scp>‐medicare analysis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/racial-disparity-in-utilization-of-therapeutic-modalities-among-multiple-myeloma/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Sikander Ailawadhi,Ryan D. Frank,Pooja Advani,Abhisek Swaika,M’hamed Temkit,Richa Menghani,Mayank Sharma,Zahara Meghji,Shumail M. Paulus,Nandita Khera,Shahrukh K. Hashmi,Aneel Paulus,Tanya Singh Kakar,David O. Hodge,Dorin Colibaseanu,Michael Vizzini,Vivek Roy,Gerardo Colón‐Otero,Asher Chanan‐Khan |
| Citations | 89 |
| DOI | 10.1002/cam4.1246 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cam4.1246 |
| OpenAlex ID | https://openalex.org/W2766415848 |
| PMID | 29105343 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Dorin Colibaseanu](https://scholariq.org/researchers/dorin-colibaseanu/)

## Paper journal

- [Cancer Medicine](https://scholariq.org/journals/cancer-medicine/)

## Paper primary topic

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)

## Paper topics

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Protein Degradation and Inhibitors](https://scholariq.org/topics/protein-degradation-and-inhibitors/)
- [Cancer therapeutics and mechanisms](https://scholariq.org/topics/cancer-therapeutics-and-mechanisms/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
